[1] ZHU L,LIU Z,ZHANG S,et al.Association between blood phosphorus level and adverse outcomes in patients with coronary artery disease:A meta analysis[J].Heliyon,2024,10(19):e38565. [2] 郭琼,石蕊,张建起,等.冠心病患者血清FFA与血脂水平的变化及其与心肌损伤程度的相关性[J].西部医学,2020,32(11):1650-1652,1657. [3] 李延芳,顾方方,闵国美,等.慢性心力衰竭合并肺炎支原体感染外周血miRNA-21/PTEN表达与心肌损伤和预后的关系[J].中华医院感染学杂志,2022,32(22):3386-3390. [4] XU Y,CAO L,ZOU W,et al.Panax notoginseng saponins inhibits NLRP3 inflammasome-mediated pyroptosis by downregulating lncRNA-ANRIL in cardiorenal syndrome type 4[J].Chin Med,2023,18(1):50. [5] 马露,杨雷,丁煌,等.冠心病血清外泌体介导的lncRNA-miRNA-mRNA ceRNA调控网络研究及潜在靶向中药预测及实验验证[J].中国药理学通报,2024,40(6):1153-1164. [6] 熊纭辉,王娟,邓海华.miR-362-3p通过MAPK1/PTEN/AKT信号通路调节冠心病大鼠心肌细胞凋亡和内皮细胞损伤[J].中西医结合心脑血管病杂志,2023,21(14):2582-2586. [7] 员小利,王丹,井海云,等.老年冠心病患者PCI术后心肌再灌注损伤与ERK/MAPK信号通路的相关性[J].中国循证心血管医学杂志,2024,16(5):561-563,568. [8] PAPPAS M A,FELDMAN L S,AUERBACH A D.Coronary disease risk prediction,risk reduction,and postoperative myocardial injury[J].Med Clin North Am,2024,108(6):1039-1051. [9] 冯莉莉,王朝华,李贺,等.microRNA-429与稳定型冠心病患者冠状动脉病变和心肌损伤相关指标的关系[J].标记免疫分析与临床,2022,29(4):657-660,704. [10] 王萌萌,金钊,张秀静,等.lncRNA-ANRIL、PON1在冠心病血清中的表达及其临床意义[J].现代生物医学进展,2022,22(9):1790-1794. [11] 宫柏琪,张琳,王娜,等.miR-181b在冠心病慢性心力衰竭患者血清中的表达及其临床意义[J].现代生物医学进展,2020,20(11):2110-2113,2041. [12] 孟宪杰,刘蕊,曹丽慧,等.长链非编码RNA MIAT在2型糖尿病合并冠心病患者血清中的水平及对高糖诱导的心肌细胞损伤的影响[J].中国动脉硬化杂志,2023,31(6):481-490. [13] 程航,夏敏.冠心病患者血清DKK-1、microRNA-181b、cTnI水平与冠脉病变程度的关系[J].武汉大学学报(医学版),2020,41(3):468-471. [14] JUSTICE C N,ZHU X,LI J,et al.Intra-ischemic hypothermia cardioprotection involves modulation of PTEN/Akt/ERK signaling and fatty acid oxidation[J].Physiol Rep,2023,11(4):e15611. [15] 何娟,蒋肖潇,何秀波.miR-19b对冠心病大鼠血管内皮细胞损伤的影响及PTEN/PI3K/AKT信号通路的作用[J].检验医学与临床,2024,21(18):2657-2663,2669. |